 |
7 Diseases |  |
0 Trials |
|
0 Trials |  |
86 News |  |
| «12 |
- | lumicitabine (JNJ-64041575) / J&J
Clinical data: Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus (clinicaltrials.gov) - Jan 19, 2017
P2b, N=90, Suspended, Sponsor: Janssen Research & Development, LLC
Recruiting --> Suspended
- | Clinical: A Study of ALS-008176 in Infants Hospitalized With RSV (clinicaltrials.gov) - Jan 9, 2017
P1, N=264, Suspended, Sponsor: Alios Biopharma Inc.
Recruiting --> Suspended N=168 --> 264 | Recruiting --> Suspended | Trial primary completion date: Sep 2016 --> Nov 2017
- P2 data, P2a data: A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus (clinicaltrials.gov) - Jan 4, 2017
P2a, N=9, Completed, Sponsor: Alios Biopharma Inc.
N=168 --> 264 | Recruiting --> Suspended | Trial primary completion date: Sep 2016 --> Nov 2017 Not yet recruiting --> Completed | Phase classification: P2 --> P2a | N=50 --> 9
- | lumicitabine (JNJ-64041575) / J&J
Clinical: A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations (clinicaltrials.gov) - Jan 3, 2017
P1, N=48, Not yet recruiting, Sponsor: Janssen Research & Development, LLC
- |||| lumicitabine (JNJ-64041575) / J&J
Clinical data: Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus (clinicaltrials.gov) - Nov 15, 2016
P2b, N=90, Recruiting, Sponsor: Janssen Research & Development, LLC
Not yet recruiting --> Completed | Phase classification: P2 --> P2a | N=50 --> 9 Not yet recruiting --> Recruiting
- |||||| lumicitabine (JNJ-64041575) / J&J
Clinical data: Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus (clinicaltrials.gov) - Oct 16, 2016
P2b, N=90, Not yet recruiting, Sponsor: Janssen Research & Development, LLC
- | lumicitabine (JNJ-64041575) / J&J
Clinical: Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants (clinicaltrials.gov) - Sep 15, 2016
P1, N=11, Completed, Sponsor: Janssen Research & Development, LLC
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| lumicitabine (JNJ-64041575) / J&J
Clinical: Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants (clinicaltrials.gov) - Jul 14, 2016
P1, N=78, Recruiting, Sponsor: Alios Biopharma Inc.
- | lumicitabine (JNJ-64041575) / J&J
Clinical: Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants (clinicaltrials.gov) - Jun 27, 2016
P1, N=12, Recruiting, Sponsor: Janssen Research & Development, LLC
- | P2 data, P2a data: A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus (clinicaltrials.gov) - Feb 4, 2016
P2, N=50, Not yet recruiting, Sponsor: Alios Biopharma Inc.
- || Clinical: A Study of ALS-008176 in Infants Hospitalized With RSV (clinicaltrials.gov) - Feb 2, 2016
P1, N=168, Recruiting, Sponsor: Alios Biopharma Inc.
Recruiting --> Completed Trial primary completion date: Nov 2015 --> Sep 2016
- | lumicitabine (JNJ-64041575) / J&J
Clinical: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants (clinicaltrials.gov) - Jul 24, 2015
P1, N=24, Completed, Sponsor: Janssen Pharmaceutical K.K.
Trial primary completion date: Nov 2015 --> Sep 2016 Active, not recruiting --> Completed
- lumicitabine (JNJ-64041575) / J&J
Clinical: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants (clinicaltrials.gov) - Jul 23, 2015
P1, N=24, Active, not recruiting, Sponsor: Janssen Pharmaceutical K.K.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | lumicitabine (JNJ-64041575) / J&J
Clinical: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants (clinicaltrials.gov) - Jun 23, 2015
P1, N=24, Recruiting, Sponsor: Janssen Pharmaceutical K.K.
- | P1 data: A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176 (clinicaltrials.gov) - Dec 24, 2014
P1, N=12, Completed, Sponsor: Alios Biopharma Inc.
Recruiting --> Active, not recruiting Recruiting --> Completed
- |||| P2 data, P2a data: A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model (clinicaltrials.gov) - Dec 24, 2014
P2, N=62, Completed, Sponsor: Alios Biopharma Inc.
Recruiting --> Completed Recruiting --> Completed
- | P1 data: A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176 (clinicaltrials.gov) - Sep 5, 2014
P1, N=12, Recruiting, Sponsor: Alios Biopharma Inc.
- ||| Clinical: A Study of ALS-008176 in Infants Hospitalized With RSV (clinicaltrials.gov) - Jul 30, 2014
P1, N=168, Recruiting, Sponsor: Alios Biopharma Inc.
- || Clinical: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers (clinicaltrials.gov) - May 12, 2014
P1, N=101, Completed, Sponsor: Alios Biopharma Inc.
Recruiting --> Completed Trial primary completion date: Sep 2013 --> Nov 2013
- | Clinical: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers (clinicaltrials.gov) - May 12, 2014
P1, N=101, Completed, Sponsor: Alios Biopharma Inc.
Trial primary completion date: Sep 2013 --> Nov 2013 Trial completion date: Sep 2013 --> Nov 2013
- || Clinical: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers (clinicaltrials.gov) - May 12, 2014
P1, N=101, Completed, Sponsor: Alios Biopharma Inc.
Trial completion date: Sep 2013 --> Nov 2013 N=144 --> 101
- ||| Clinical: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers (clinicaltrials.gov) - May 12, 2014
P1, N=101, Completed, Sponsor: Alios Biopharma Inc.
N=144 --> 101 Recruiting --> Completed
- ||||| P2 data, P2a data: A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model (clinicaltrials.gov) - Mar 19, 2014
P2, N=66, Recruiting, Sponsor: Alios Biopharma Inc.
- ||| Clinical: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers (clinicaltrials.gov) - Jul 22, 2013
P1, N=144, Recruiting, Sponsor: Alios Biopharma Inc.
- ||| Clinical: Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers (clinicaltrials.gov) - Jul 22, 2013
P1, N=144, Recruiting, Sponsor: Alios Biopharma Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting